Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Cash from Financing Activities (2022 - 2025)

Prokidney (PROK) has disclosed Cash from Financing Activities for 4 consecutive years, with $17.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 14236.59% to $17.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.6 million through Dec 2025, down 82.29% year-over-year, with the annual reading at $25.6 million for FY2025, 82.29% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $17.6 million at Prokidney, up from $8.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $507.5 million in Q3 2022, with the low at -$9.5 million in Q4 2023.
  • Average Cash from Financing Activities over 4 years is $44.3 million, with a median of $57500.0 recorded in 2022.
  • The sharpest move saw Cash from Financing Activities tumbled 118800.0% in 2023, then skyrocketed 1075807.69% in 2024.
  • Over 4 years, Cash from Financing Activities stood at -$8000.0 in 2022, then crashed by 118800.0% to -$9.5 million in 2023, then skyrocketed by 101.29% to $123000.0 in 2024, then soared by 14236.59% to $17.6 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $17.6 million, $8.0 million, and -$14000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.